🇺🇸 FDA
Pipeline program

NIO752, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung

CNIO752A12301

Phase 3 small_molecule active

Quick answer

NIO752, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung for Participants with Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Participants with Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials